1 | ischemic | 10,204 |
2 | ischaemic | 2,703 |
3 | cardioembolic | 131 |
4 | recruitable | 105 |
5 | non-disabling | 22 |
6 | terrorist | 21 |
7 | nonlacunar | 19 |
8 | acute/rehabilitation | 17 |
9 | preload-recruitable | 16 |
10 | pfo-related | 13 |
11 | neurovisceral | 11 |
12 | ce/af | 7 |
13 | munster | 7 |
14 | af-associated | 6 |
15 | postpremature | 6 |
16 | pressure-overload-induced | 6 |
17 | first-ever-in-a-lifetime | 5 |
18 | non-hemorrhagic | 5 |
19 | adams-stokes | 4 |
20 | carotid-related | 4 |
21 | european/australasian | 4 |
22 | ischemia-like | 4 |
23 | stroke/no | 4 |
24 | 'ischemic | 3 |
25 | anterior-circulation | 3 |
26 | atherosclerotic/lacunar | 3 |
27 | auxotonic | 3 |
28 | cardio-embolic | 3 |
29 | infarction-induced | 3 |
30 | noncuffed | 3 |
31 | unclear-onset | 3 |
32 | 'non-fatal | 2 |
33 | attack/minor | 2 |
34 | burn-only | 2 |
35 | carotid-territory | 2 |
36 | cutaneous/abdominal | 2 |
37 | ferocious | 2 |
38 | hypoperfusion-related | 2 |
39 | i/r-associated | 2 |
40 | initial/first | 2 |
41 | ischemic/hemorrhagic | 2 |
42 | tia/minor | 2 |
43 | 'european/australasian | 1 |
44 | 'hemorrhagic | 1 |
45 | //www.controlled-trials.com/isrctn52519535/ | 1 |
46 | 0.9/ | 1 |
47 | 186+/-7 | 1 |
48 | 19,820 | 1 |
49 | 20,885 | 1 |
50 | 243,000 | 1 |
51 | 42,401 | 1 |
52 | 5-paced/15-nonpaced | 1 |
53 | 577,000 | 1 |
54 | 7,108 | 1 |
55 | 9,550 | 1 |
56 | attack/ischemic | 1 |
57 | blackouts/fainting | 1 |
58 | bottom-face | 1 |
59 | cataplectic | 1 |
60 | chelate-enhanced | 1 |
61 | cilliary | 1 |
62 | cilostazol-induced | 1 |
63 | concave-upward | 1 |
64 | conditions.adverse | 1 |
65 | ct-alberta | 1 |
66 | disabling/fatal | 1 |
67 | disease/transischemic | 1 |
68 | ecass-1 | 1 |
69 | emboligenic | 1 |
70 | fatal/nonfatal/no | 1 |
71 | first-ever-ischemic | 1 |
72 | first-in-a-lifetime | 1 |
73 | heat/sun | 1 |
74 | hyper-enhancement | 1 |
75 | hypertension-based | 1 |
76 | induced-heat | 1 |
77 | infarctive | 1 |
78 | ischaemo-haemorrhagic | 1 |
79 | ischeamic | 1 |
80 | major/disabling | 1 |
81 | neurological-recurrent | 1 |
82 | ninds-canadian | 1 |
83 | non-classifiables | 1 |
84 | non-perioperative | 1 |
85 | noncardioembolic/nonatheroembolic | 1 |
86 | noncerebellar | 1 |
87 | nonsemai | 1 |
88 | ofsecondary | 1 |
89 | palsy-associated | 1 |
90 | paludal | 1 |
91 | pericardioversion | 1 |
92 | petn-induced | 1 |
93 | prefacing | 1 |
94 | rain-filled | 1 |
95 | right-brain-damaged | 1 |
96 | rilonacept-placebo | 1 |
97 | s1q3t3 | 1 |
98 | self-terminated | 1 |
99 | sharing-1 | 1 |
100 | stroke-international | 1 |
101 | study-ischemic | 1 |
102 | sub-perception-treated | 1 |
103 | sumatriptan/naproxen-treated | 1 |
104 | terroristic | 1 |
105 | thomboembolic | 1 |
106 | tia/ischaemic | 1 |
107 | torsion-induced | 1 |
108 | transient-ischemic | 1 |
109 | volume-la | 1 |
1 | 'european/australasian | 1 |
2 | 'hemorrhagic | 1 |
3 | 'ischemic | 3 |
4 | 'non-fatal | 2 |
5 | //www.controlled-trials.com/isrctn52519535/ | 1 |
6 | 0.9/ | 1 |
7 | 186+/-7 | 1 |
8 | 19,820 | 1 |
9 | 20,885 | 1 |
10 | 243,000 | 1 |
11 | 42,401 | 1 |
12 | 5-paced/15-nonpaced | 1 |
13 | 577,000 | 1 |
14 | 7,108 | 1 |
15 | 9,550 | 1 |
16 | acute/rehabilitation | 17 |
17 | adams-stokes | 4 |
18 | af-associated | 6 |
19 | anterior-circulation | 3 |
20 | atherosclerotic/lacunar | 3 |
21 | attack/ischemic | 1 |
22 | attack/minor | 2 |
23 | auxotonic | 3 |
24 | blackouts/fainting | 1 |
25 | bottom-face | 1 |
26 | burn-only | 2 |
27 | cardio-embolic | 3 |
28 | cardioembolic | 131 |
29 | carotid-related | 4 |
30 | carotid-territory | 2 |
31 | cataplectic | 1 |
32 | ce/af | 7 |
33 | chelate-enhanced | 1 |
34 | cilliary | 1 |
35 | cilostazol-induced | 1 |
36 | concave-upward | 1 |
37 | conditions.adverse | 1 |
38 | ct-alberta | 1 |
39 | cutaneous/abdominal | 2 |
40 | disabling/fatal | 1 |
41 | disease/transischemic | 1 |
42 | ecass-1 | 1 |
43 | emboligenic | 1 |
44 | european/australasian | 4 |
45 | fatal/nonfatal/no | 1 |
46 | ferocious | 2 |
47 | first-ever-in-a-lifetime | 5 |
48 | first-ever-ischemic | 1 |
49 | first-in-a-lifetime | 1 |
50 | heat/sun | 1 |
51 | hyper-enhancement | 1 |
52 | hypertension-based | 1 |
53 | hypoperfusion-related | 2 |
54 | i/r-associated | 2 |
55 | induced-heat | 1 |
56 | infarction-induced | 3 |
57 | infarctive | 1 |
58 | initial/first | 2 |
59 | ischaemic | 2,703 |
60 | ischaemo-haemorrhagic | 1 |
61 | ischeamic | 1 |
62 | ischemia-like | 4 |
63 | ischemic | 10,204 |
64 | ischemic/hemorrhagic | 2 |
65 | major/disabling | 1 |
66 | munster | 7 |
67 | neurological-recurrent | 1 |
68 | neurovisceral | 11 |
69 | ninds-canadian | 1 |
70 | non-classifiables | 1 |
71 | non-disabling | 22 |
72 | non-hemorrhagic | 5 |
73 | non-perioperative | 1 |
74 | noncardioembolic/nonatheroembolic | 1 |
75 | noncerebellar | 1 |
76 | noncuffed | 3 |
77 | nonlacunar | 19 |
78 | nonsemai | 1 |
79 | ofsecondary | 1 |
80 | palsy-associated | 1 |
81 | paludal | 1 |
82 | pericardioversion | 1 |
83 | petn-induced | 1 |
84 | pfo-related | 13 |
85 | postpremature | 6 |
86 | prefacing | 1 |
87 | preload-recruitable | 16 |
88 | pressure-overload-induced | 6 |
89 | rain-filled | 1 |
90 | recruitable | 105 |
91 | right-brain-damaged | 1 |
92 | rilonacept-placebo | 1 |
93 | s1q3t3 | 1 |
94 | self-terminated | 1 |
95 | sharing-1 | 1 |
96 | stroke-international | 1 |
97 | stroke/no | 4 |
98 | study-ischemic | 1 |
99 | sub-perception-treated | 1 |
100 | sumatriptan/naproxen-treated | 1 |
101 | terrorist | 21 |
102 | terroristic | 1 |
103 | thomboembolic | 1 |
104 | tia/ischaemic | 1 |
105 | tia/minor | 2 |
106 | torsion-induced | 1 |
107 | transient-ischemic | 1 |
108 | unclear-onset | 3 |
109 | volume-la | 1 |
1 | //www.controlled-trials.com/isrctn52519535/ | 1 |
2 | 0.9/ | 1 |
3 | 243,000 | 1 |
4 | 577,000 | 1 |
5 | 19,820 | 1 |
6 | 9,550 | 1 |
7 | sharing-1 | 1 |
8 | ecass-1 | 1 |
9 | 42,401 | 1 |
10 | s1q3t3 | 1 |
11 | 20,885 | 1 |
12 | 186+/-7 | 1 |
13 | 7,108 | 1 |
14 | volume-la | 1 |
15 | ct-alberta | 1 |
16 | ischaemo-haemorrhagic | 1 |
17 | 'hemorrhagic | 1 |
18 | non-hemorrhagic | 5 |
19 | ischemic/hemorrhagic | 2 |
20 | cardio-embolic | 3 |
21 | thomboembolic | 1 |
22 | cardioembolic | 131 |
23 | noncardioembolic/nonatheroembolic | 1 |
24 | ischeamic | 1 |
25 | ischaemic | 2,703 |
26 | tia/ischaemic | 1 |
27 | ischemic | 10,204 |
28 | 'ischemic | 3 |
29 | first-ever-ischemic | 1 |
30 | transient-ischemic | 1 |
31 | study-ischemic | 1 |
32 | attack/ischemic | 1 |
33 | disease/transischemic | 1 |
34 | emboligenic | 1 |
35 | auxotonic | 3 |
36 | cataplectic | 1 |
37 | terroristic | 1 |
38 | 5-paced/15-nonpaced | 1 |
39 | chelate-enhanced | 1 |
40 | pressure-overload-induced | 6 |
41 | cilostazol-induced | 1 |
42 | torsion-induced | 1 |
43 | infarction-induced | 3 |
44 | petn-induced | 1 |
45 | noncuffed | 3 |
46 | right-brain-damaged | 1 |
47 | rain-filled | 1 |
48 | hypertension-based | 1 |
49 | sumatriptan/naproxen-treated | 1 |
50 | sub-perception-treated | 1 |
51 | af-associated | 6 |
52 | i/r-associated | 2 |
53 | palsy-associated | 1 |
54 | carotid-related | 4 |
55 | hypoperfusion-related | 2 |
56 | pfo-related | 13 |
57 | self-terminated | 1 |
58 | concave-upward | 1 |
59 | bottom-face | 1 |
60 | ischemia-like | 4 |
61 | recruitable | 105 |
62 | preload-recruitable | 16 |
63 | first-ever-in-a-lifetime | 5 |
64 | first-in-a-lifetime | 1 |
65 | postpremature | 6 |
66 | conditions.adverse | 1 |
67 | non-perioperative | 1 |
68 | infarctive | 1 |
69 | ce/af | 7 |
70 | prefacing | 1 |
71 | non-disabling | 22 |
72 | major/disabling | 1 |
73 | blackouts/fainting | 1 |
74 | nonsemai | 1 |
75 | paludal | 1 |
76 | cutaneous/abdominal | 2 |
77 | stroke-international | 1 |
78 | neurovisceral | 11 |
79 | 'non-fatal | 2 |
80 | disabling/fatal | 1 |
81 | ninds-canadian | 1 |
82 | european/australasian | 4 |
83 | 'european/australasian | 1 |
84 | pericardioversion | 1 |
85 | anterior-circulation | 3 |
86 | acute/rehabilitation | 17 |
87 | heat/sun | 1 |
88 | rilonacept-placebo | 1 |
89 | stroke/no | 4 |
90 | fatal/nonfatal/no | 1 |
91 | noncerebellar | 1 |
92 | atherosclerotic/lacunar | 3 |
93 | nonlacunar | 19 |
94 | munster | 7 |
95 | tia/minor | 2 |
96 | attack/minor | 2 |
97 | adams-stokes | 4 |
98 | non-classifiables | 1 |
99 | ferocious | 2 |
100 | induced-heat | 1 |
101 | unclear-onset | 3 |
102 | hyper-enhancement | 1 |
103 | neurological-recurrent | 1 |
104 | terrorist | 21 |
105 | initial/first | 2 |
106 | burn-only | 2 |
107 | ofsecondary | 1 |
108 | cilliary | 1 |
109 | carotid-territory | 2 |